We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+37.44%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.04B
AUM Growth
+$198M
Cap. Flow
+$14M
Cap. Flow %
1.35%
Top 10 Hldgs %
42.78%
Holding
150
New
56
Increased
28
Reduced
29
Closed
29

Top Buys

Rank Stock Value
1
ATRC icon
AtriCure
ATRC
+$12.9M
2
LHCG
LHC Group LLC
LHCG
+$9.74M
3
CNMD icon
CONMED
CNMD
+$7.65M
4
LIVN icon
LivaNova
LIVN
+$7.59M
5
IMVT icon
Immunovant
IMVT
+$5.8M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.47M
2
XLRN
Acceleron Pharma
XLRN
+$5.43M
3
STAA icon
STAAR Surgical
STAA
+$5.36M
4
QDEL icon
QuidelOrtho
QDEL
+$5.09M
5
ADPT icon
Adaptive Biotechnologies
ADPT
+$4.68M

Sector Composition

Rank Sector Weight
1 Healthcare 38.45%
2 Industrials 1.39%
3 Energy 1.11%
4 Consumer Discretionary 0.31%
5 Consumer Staples 0.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NSTG
76
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
$2.99M 0.29%
+102,000
New +$3.04M
MRSN
77
DELISTED
Mersana Therapeutics
MRSN
$2.99M 0.29%
+5,116
New +$1.75M
MYOK
78
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$2.78M 0.27%
+28,800
New +$2.4M
NARI
79
DELISTED
Inari Medical, Inc. Common Stock
NARI
$2.77M 0.27%
+57,125
New +$2.73M
TGTX icon
80
TG Therapeutics
TGTX
$7.6B
$2.75M 0.26%
141,364
-37,600
-21% -$606K
ARDX icon
81
Ardelyx
ARDX
$1.02B
$2.74M 0.26%
396,541
+72,900
+23% +$507K
GTH
82
DELISTED
Genetron Holdings Limited ADS
GTH
$2.62M 0.25%
+72,267
New +$2.93M
LYRA
83
DELISTED
LYRA THERAPEUTICS INC
LYRA
$2.25M 0.22%
+3,960
New +$2.89M
NUVA
84
PUT
DELISTED
NuVasive, Inc.
NUVA
$2.09M 0.2%
+37,500
New +$2.17M
BCRX icon
85
BioCryst Pharmaceuticals
BCRX
$2.7B
$2.08M 0.2%
+436,500
New +$1.74M
IRTC icon
86
PUT
iRhythm Holdings
IRTC
$4.08B
$2.03M 0.2%
+17,500
New +$1.93M
XLRN
87
DELISTED
Acceleron Pharma
XLRN
$1.94M 0.19%
20,400
-56,281
-73% -$5.43M
AMRN
88
Amarin Corp
AMRN
$298M
$1.77M 0.17%
12,812
-17,504
-58% -$2.41M
BMY.RT
89
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$1.65M 0.16%
461,622
+262,882
+132% +$948K
CHAQ.U
90
DELISTED
Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one
CHAQ.U
$1.62M 0.16%
+153,960
New +$1.55M
FLXN
91
DELISTED
Flexion Therapeutics, Inc.
FLXN
$1.61M 0.16%
+122,800
New +$1.27M
GNLN icon
92
Greenlane Holdings
GNLN
$1.19M
– –
0
– –
FOLD
93
DELISTED
Amicus Therapeutics
FOLD
$1.54M 0.15%
+102,300
New +$1.25M
CRBP icon
94
CALL
Corbus Pharmaceuticals
CRBP
$187M
$1.46M 0.14%
5,797
+134
+2% +$27.1K
XENT
95
CALL
DELISTED
Intersect ENT, Inc
XENT
$1.38M 0.13%
+102,000
New +$1.19M
LQDA icon
96
Liquidia Corp
LQDA
$7.09B
$1.26M 0.12%
+150,000
New +$1.14M
CNST
97
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$1.23M 0.12%
+40,900
New +$1.47M
MCRB icon
98
CALL
Seres Therapeutics
MCRB
$46.9M
$1.22M 0.12%
+12,800
New +$1.12M
QURE icon
99
uniQure
QURE
$3.12B
$1.15M 0.11%
+25,600
New +$1.51M
PSNL icon
100
Personalis
PSNL
$1.51B
$1.13M 0.11%
+87,211
New +$968K
2 3
4
5 6

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q2 2020 Portfolio in Review

As of Q2 2020, Pura Vida Investments held 150 positions worth $1.04B, up 23% from $842M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Pura Vida Investments's Q2 2020 filing shows 56 new, 28 increased, 29 reduced and 29 closed positions. Its largest new stake was LHC Group LLC: 66,359 shares worth $11.6M. The largest sale was Regeneron Pharmaceuticals, an estimated $5.47M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Industrials and Energy.

  • Pura Vida Investments's largest Q2 2020 buy was LHC Group LLC: 66,359 shares worth $11.6M.
  • Pura Vida Investments added most to AtriCure in Q2 2020, an estimated $12.9M increase.
  • Pura Vida Investments's biggest Q2 2020 reduction was Acceleron Pharma, cutting an estimated $5.43M.
  • Pura Vida Investments fully exited Regeneron Pharmaceuticals in Q2 2020, selling an estimated $5.47M.
  • Pura Vida Investments's ten largest holdings make up 43% of its $1.04B portfolio in Q2 2020.
  • Pura Vida Investments opened 56 new positions and closed 29 in Q2 2020.
  • Pura Vida Investments's portfolio value rose 23% quarter-over-quarter to $1.04B.

Based on Pura Vida Investments's 13F filing for Q2 2020, filed 14 Aug 2020.